Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease

Altres autors/es

Institut Català de la Salut

[Llàcer P] Internal Medicine Department, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain. Department of Medicine and Medical Specialties, Facultad de Medicina y Ciencias de la Salud, Universidad de Alcalá, Madrid, Spain. [Cobo Marcos M] Department of Cardiology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain. Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares, Madrid, Spain. [de la Espriella R] Department of Cardiology, Hospital Clínico Universitario de Valencia, Valencia, Spain. [Gayán Ordás J] Department of Cardiology, Hospital Universitario Arnau de Vilanova, Institut de Recerca Biomèdica de Lleida, Lleida, Spain. [Zegri I] Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain. [Fort A] Department of Cardiology, Hospital Universitari Dr Josep Trueta, Girona, Spain. [Méndez A] Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Soler MJ] Servei de Nefrologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Data de publicació

2024-06-10T10:40:23Z

2024-06-10T10:40:23Z

2024-05-15



Resum

Albuminuria; Cardiorenal disease; Congestion


Albuminúria; Malaltia cardiorenal; Congestió


Albuminuria; Enfermedad cardiorrenal; Congestión


Background Albuminuria could potentially emerge as a novel marker of congestion in acute heart failure. However, the current evidence linking albuminuria and congestion in patients with congestive heart failure (CHF) remains somewhat scarce. This study aimed to evaluate the prevalence of albuminuria in a cohort of patients with CHF, identify the independent factors associated with albuminuria and analyse the correlation with different congestion parameters. Methods This is a subanalysis of the Spanish Cardiorenal Registry, in which we enrolled 864 outpatients with heart failure and a value of urinary albumin:creatinine ratio (UACR) at the first visit. Results The median age was 74 years, 549 (63.5%) were male and 438 (50.7%) had a reduced left ventricular ejection fraction. A total of 350 patients (40.5%) had albuminuria. Among these patients, 386 (33.1%) had a UACR of 30–300 mg/g and 64 (7.4%) had a UACR >300 mg/g. In order of importance, the independent variables associated with higher UACR were estimated glomerular filtration rate determined by the Chronic Kidney Disease Epidemiology Collaboration equation (R2 = 57.6%), systolic blood pressure (R2 = 21.1%), previous furosemide equivalent dose (FED; R2 = 7.5%), antigen carbohydrate 125 (CA125; R2 = 6.1%), diabetes mellitus (R2 = 5.6%) and oedema (R2 = 1.9%). The combined influence of oedema, elevated CA125 levels and the FED accounted for 15.5% of the model's variability. Conclusions In patients with chronic stable heart failure, the prevalence of albuminuria is high. The risk factors of albuminuria in this population are chronic kidney disease and hypertension. Congestion parameters are also associated with increased albuminuria.


We have received funding to produce this article from Astra Zeneca.

Tipus de document

Article


Versió publicada

Llengua

Anglès

Publicat per

Oxford University Press

Documents relacionats

Clinical Kidney Journal;17(6)

https://doi.org/10.1093/ckj/sfae140

Citació recomanada

Aquesta citació s'ha generat automàticament.

Drets

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

Aquest element apareix en la col·lecció o col·leccions següent(s)